title: Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation.
authors.forename: S
authors.initials: S
authors.lastname: Girnius
authors.forename: D C
authors.initials: DC
authors.lastname: Seldin
authors.forename: K
authors.initials: K
authors.lastname: Quillen
authors.forename: L M
authors.initials: LM
authors.lastname: Dember
authors.forename: A
authors.initials: A
authors.lastname: Segal
authors.forename: V
authors.initials: V
authors.lastname: Sanchorawala
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000378:metabolism*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D019653:Myeloablative Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010265:Paraproteinemias / Q000188:drug therapy* / Q000378:metabolism / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D014182:Transplantation, Autologous / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D019653:Myeloablative Agonists; D008558:Melphalan
references.citation: Nephrol Dial Transplant. 2008 Jun;23(6):2052-7
references.pmid: 18178602
references.citation: Ann Intern Med. 2004 Jan 20;140(2):85-93
references.pmid: 14734330
references.citation: Kidney Int. 2004 Feb;65(2):642-8
references.pmid: 14717936
references.citation: Clin J Am Soc Nephrol. 2007 Jul;2(4):858-67
references.pmid: 17699503
references.citation: Haematologica. 2009 Feb;94(2):300-2
references.pmid: 19066331
references.citation: Am J Kidney Dis. 2003 Dec;42(6):1154-63
references.pmid: 14655186
references.citation: Bone Marrow Transplant. 2006 Sep;38(5):339-43
references.pmid: 16862166
references.citation: Bone Marrow Transplant. 2008 Sep;42(6):405-12
references.pmid: 18574442